Biofil Chemicals & Pharmaceuticals Limited — Others, 28-06-2025: Disclosure under SEBI Takeover Regulations

Biofil Chemicals and Pharmaceuticals’ promoter group and persons acting in concert hold 76.19 lakh equity shares as of the financial year-end and have not created any encumbrance on these shares during the year. This stability in shareholding and absence of pledged shares reflects confidence and reduces concerns over potential forced selling, supporting shareholder interests.